Name: Aspire Biopharma Holdings, Inc. (ASBP) Cash Flow Statement
Creator: FinSpry

Aspire Biopharma Holdings Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Aspire Biopharma Holdings, Inc. (ASBP) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Operating Activities
Net Income	-1.31	-0.36	-0.60
Change in Working Capital	1.04	0.37	0.45
Change in Accounts Receivable	-0.04	0.00	0.00
Change in Accounts Payable	0.00	0.05	0.10
Change in Other Working Capital	1.07	0.32	0.35
Other Operating Activities	0.01	0.00	0.00
Net Cash from Operating Activities	-0.27	0.01	-0.14
Investing Activities
Capital Expenditures	0.00	-0.08	-4.90
Sales/Maturities of Investments	13.78	0.00	-4.90
Other Investing Activities	-13.78	0.00	0.00
Net Cash from Investing Activities	0.00	0.00	-4.90
Financing Activities
Debt Repayment	1.71	0.00	0.00
Common Stock Issued	0.26	0.00	1.00
Common Stock Repurchased	-13.78	0.00	0.00
Other Financing Activities	11.98	0.00	3.85
Net Cash from Financing Activities	0.26	0.00	4.85
Summary
Net Change in Cash	-0.01	0.01	-0.19
Cash at Beginning of Period	0.01	0.00	0.19
Cash at End of Period	0.00	0.01	0.00
Free Cash Flow	-0.27	0.01	-5.04
Supplemental Disclosures
Income Taxes Paid	0.00	0.00	0.00